title: Lack of the effect of bumetanide, a selective NKCC1 inhibitor, in patients with schizophrenia: A double-blind randomized trial.
authors: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
authors: Reza
authors: R
authors: Rahmanzadeh
authors: Faculty of Advanced Technologies in Medicine, Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran.
authors: Ali
authors: A
authors: Shahbazi
authors: Razi Psychiatric Hospital, University of Social Welfare and Rehabilitation, Tehran, Iran.
authors: Mohammad-Reza Khodaei
authors: MK
authors: Ardakani
authors: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
authors: Soraya
authors: S
authors: Mehrabi
authors: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
authors: Ramin
authors: R
authors: Rahmanzade
authors: Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.|Faculty of Advanced Technologies in Medicine, Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran.
authors: Mohammad Taghi
authors: MT
authors: Joghataei
mesh_terms: D002034:Bumetanide / Q000494:pharmacology*; D004311:Double-Blind Method; D006801:Humans; D017063:Outcome Assessment, Health Care; D012559:Schizophrenia / Q000188:drug therapy*; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000494:pharmacology*
chemical_list: D049994:Sodium Potassium Chloride Symporter Inhibitors; D002034:Bumetanide